Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract Phacoemulsification

NCT07696104 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Pseudophakic Cystoid Macular Edema

Interventions

DRUG: Bromfenac 0.09 % Ophthalmic Solution
DRUG: Bromfenac 0.09 % Ophthalmic Solution
DRUG: Nepafenac 0.1% eyedrops
DRUG: diclofenac 0.1% ophthalmic susp.

Sponsor

Pomeranian Medical University Szczecin